Advancing Personalized Care in Rheumatoid Arthritis: A Novel Framework Using NNT, ARR, and Quality of Life Metrics
Identification
- Clé publique
- radar:r-4e4d90ea9d23a913d9d60e2bca833e0d
- Auteurs
- Daniela Viorelia Matei · Anca Maria Amzolini · Miruna Andreiana Matei · Anda Pătru · Mihai Cealicu · Maria Teodora Amzolini · Magdalena Rodica Trăistaru · Ana Maria Bumbea · Constantin Munteanu · Simona Pătru
- Année déclarée
- 2025
- Langue déclarée
- en
- Type source
- article
- Première détection
- 2026-11-13T12:44:36.165909+00:00
- Dernière observation des métadonnées
- 2026-11-13T12:44:36.165909+00:00
- Dernière vérification HTTP
- Non effectuée
Institutions déclarées par la source
University of Medicine and Pharmacy of Craiova · Universitat de València · Grigore T. Popa University of Medicine and Pharmacy
Pays d’affiliation déclarés
ES · RO
Résumé documentaire — langue originale
This study evaluates the efficacy of monotherapy versus combination therapy in rheumatoid ar-thritis (RA) using advanced quantitative metrics such as Number Needed to Treat (NNT), Absolute Risk Reduction (ARR), Relative Risk Reduction (RRR), and Control and Experimental Event Rates (CER and EER). The goal is to provide a structured, clinically relevant framework for op-timizing RA management and bridging the gap between clinical research and real-world appli-cation. A prospective cohort study included 160 RA patients, stratified by age, gender, and dis-ease activity. Patients received either monotherapy (MTX or LEF) or combination therapy (MTX/SSZ/HCQ). Outcomes were assessed over 24 months using statistical significance measures such as confidence intervals, t-tests, ANOVA, and non-parametric alternatives. The findings provide a direct clinical application, guiding treatment selection based on quantifiable response metrics. NNT, ARR, RRR, CER, and EER were calculated to evaluate treatment effectiveness. Combination therapy (MTX/SSZ/HCQ) demonstrated superior efficacy with an NNT of 3, compared to 25 for monotherapy. ARR and RRR were 71% and 90%, respectively, for combination therapy versus MTX/HCQ. Quality of life scores significantly improved in the combination therapy group, correlating with sustained remission over 24 months. This study presents a practical tool for clinicians by integrating longitudinal metrics and patient-specific NNT to personalize RA treatment decisions. By integrating longitudinal metrics and patient-specific NNT, it provides a novel, evidence-based approach to improving treatment outcomes in RA.
Identifiants
- OPENALEX
- https://openalex.org/W4409184193
- DOI
- 10.12680/balneo.2025.789
Repères documentaires
- Famille documentaire
- article
- Types déclarés par les sources
- article
- Éditeurs
- Romanian Association of Balneology
Les mentions d’entités ne constituent pas une preuve de reconnaissance juridique. La juridiction étudiée est distincte du pays d’affiliation des auteurs.
Sources
OpenAlex · Document 1
Citer cette référence
Daniela Viorelia Matei; Anca Maria Amzolini; Miruna Andreiana Matei; Anda Pătru; Mihai Cealicu; Maria Teodora Amzolini; Magdalena Rodica Trăistaru; Ana Maria Bumbea; Constantin Munteanu; Simona Pătru. Advancing Personalized Care in Rheumatoid Arthritis: A Novel Framework Using NNT, ARR, and Quality of Life Metrics. 2025. https://doi.org/10.12680/balneo.2025.789
JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·
APA, Chicago, ISO 690 : formats bibliographiques fondés sur les champs disponibles. OSCOLA / Bluebook : données structurées uniquement ; aucune conformité juridique complète n’est revendiquée sans vérification des éléments nécessaires.
- APA
- Daniela Viorelia Matei; Anca Maria Amzolini; Miruna Andreiana Matei; Anda Pătru; Mihai Cealicu; Maria Teodora Amzolini; Magdalena Rodica Trăistaru; Ana Maria Bumbea; Constantin Munteanu; Simona Pătru. (2025). Advancing Personalized Care in Rheumatoid Arthritis: A Novel Framework Using NNT, ARR, and Quality of Life Metrics. https://doi.org/10.12680/balneo.2025.789
- Chicago
- Daniela Viorelia Matei; Anca Maria Amzolini; Miruna Andreiana Matei; Anda Pătru; Mihai Cealicu; Maria Teodora Amzolini; Magdalena Rodica Trăistaru; Ana Maria Bumbea; Constantin Munteanu; Simona Pătru. Advancing Personalized Care in Rheumatoid Arthritis: A Novel Framework Using NNT, ARR, and Quality of Life Metrics. 2025. https://doi.org/10.12680/balneo.2025.789
- ISO 690
- Daniela Viorelia Matei; Anca Maria Amzolini; Miruna Andreiana Matei; Anda Pătru; Mihai Cealicu; Maria Teodora Amzolini; Magdalena Rodica Trăistaru; Ana Maria Bumbea; Constantin Munteanu; Simona Pătru. Advancing Personalized Care in Rheumatoid Arthritis: A Novel Framework Using NNT, ARR, and Quality of Life Metrics. 2025. https://doi.org/10.12680/balneo.2025.789
Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31
UDTR — Bibliothèque juridique mondiale des droits de la Nature. Advancing Personalized Care in Rheumatoid Arthritis: A Novel Framework Using NNT, ARR, and Quality of Life Metrics. Notice documentaire: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-4e4d90ea9d23a913d9d60e2bca833e0d/ · Dernière vérification HTTP : non effectuée
Données de cette version figée
Dossiers et relations documentaires
Rôles des sources
Source bibliographique / publication d’origine · https://doi.org/10.12680/balneo.2025.789
Un lien vers une autorité ne prouve pas à lui seul une affirmation juridique. Les résumés et les textes intégraux restent soumis aux conditions de leur source.
Statut documentaire
Pertinence à examiner
Bibliothèque
Cette identité n’est pas encore intégrée à la Bibliothèque juridique.